Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Xiangwei Pharmaceutical is a Chinese pharmaceutical company specializing in the production and distribution of Traditional Chinese Medicine (TCM) and herbal products. Founded in 1965 as a processing facility for the renowned Beijing Tongrentang, the company has evolved into a modern manufacturer of TCM decoction pieces and herbal-based drugs. It operates a GMP-certified facility in the Changping District of Beijing and is a subsidiary of Beijing Boran Pharmaceutical. The company's product range includes various forms of herbal medicines such as direct oral decoction pieces, sliced, and steamed herbs, serving hospitals and pharmacies across China. Its parent company, Beijing Boran, was acquired by China Health Holding in 2007, integrating Xiangwei into a broader portfolio of healthcare assets focused on chronic diseases like diabetes and cardiovascular conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Xiangwei Herbal Medicinal.